Skin as a surrogate tissue for pharmacodynamic end points: is it deep enough?
Baselga
Jose
J
D002986:Clinical Trials as Topic; D017277:Drug Approval / Q000379:methods*; D015195:Drug Design; D015507:Drugs, Investigational; D066246:ErbB Receptors / Q000037:antagonists & inhibitors; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*; D012867:Skin / Q000187:drug effects*; D012879:Skin Physiological Phenomena
D015507:Drugs, Investigational; D066246:ErbB Receptors